Search results
Launching an Obesity Medicine Practice? Key Considerations
Medscape· 5 days agoWith the demand for anti-obesity drugs continuing to soar and the provision of supportive care that...
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Yahoo Finance via AOL· 4 days agoAmgen's (AMGN) positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its...
Small Bowel Microbiome Profiles Differ in Overweight/Obesity
Medscape· 5 days agoResearchers have identified significant and specific variations in the microbial universe of the...
A real fat burner, this little-used vegetable is the best way to lose weight this summer!
CCM· 22 hours agoThere's no miracle recipe, but this little-used vegetable is a real ally in maintaining a healthy,...
Obesity, poor diet & physical inactivity driving early onset of cancers: Health expert
Investing.com· 4 days agoNew Delhi, May 4 (IANS) Obesity, poor diet, and physical inactivity are driving the onset of several...
States consider whether to add coverage for some obesity medicines
WUNC Chapel Hill· 14 hours agoMedicaid is required to cover almost all drugs, but Congress specifically excluded those for weight loss. Even so, 16 states now cover Wegovy. Others are considering it, but it could strain budgets.
Amgen stock soars on positive obesity drug update, analysts raise PT By Investing.com
Investing.com· 5 days agoOn Thursday, Amgen (NASDAQ:AMGN) is discontinuing its experimental weight loss pill, choosing...
A New Way To Treat Obesity? Scientists Discover Surprising Effects of New Drug
SciTechDaily· 3 days agoResearchers at Karolinska Institute have potentially discovered a novel method to combat obesity and...
Amgen axes obesity asset after phase 1 results, zooms in on MariTide
FierceBiotech· 5 days agoAmgen is axing obesity candidate AMG 786 and going all in on later-stage asset MariTide. “Given the...
Where Is Amgen Headed After the Stock Surges on Obesity Drug News?
TheStreet.com· 5 days agoShares of Amgen (AMGN) are soaring higher Friday morning after the biopharma company's CEO gave a...